Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells

Cancer Research

Volumn 62, Issue 4, 2002, Pages 1008-1013

  Zegarra Moro, Ofelia L ^a   Schmidt, Lucy J ^a   Huang, Haojie ^a   Tindall, Donald J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; RIBOZYME;

ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MICROINJECTION; PRIORITY JOURNAL; PROSTATE CANCER; WESTERN BLOTTING;

ANDROGEN ANTAGONISTS; ANTIBODIES, NEOPLASM; CELL DIVISION; DRUG RESISTANCE, NEOPLASM; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, CATALYTIC;

EID: 0036170838     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ligand dependent and independent activation of the androgen receptor
2. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer
3. Androgen receptors in endocrine therapy-resistant human prostate cancer
4. Molecular basis of androgen receptor diseases. Trends in molecular medicine
5. The role of the androgen receptor in the development and progression of prostate cancer
6. Prostate cancer: Molecular biology of early progression to androgen independent
7. Intracellular neutralization of SV40 tumor antigen following microinjection of specific antibodies
8. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP
9. Structure and mechanism of the hammeribozyme self-cleaving domain
10. Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammeribozyme
11. Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer
12. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
13. Androgen receptor gene mutations in hormone-refractory prostate cancer
14. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
15. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
16. Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: Relation to anti-androgen withdrawal syndrome
17. Androgen receptor activation in prostate tumor cell lines by insulin-like growth factor-1, keratinocyte growth factor, and epidermal growth factor
18. Ligand-independent activation of the androgen receptor in prostate cancer by growth factors and cytokines
19. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
20. Androgen independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways
21. Nuclear receptor coactivators and corepressors
22. Amplification of AR is associated with p53 mutation in hormone refractory recurrent prostate cancer